α-𝐒đČđ§đźđœđ„đžđąđ§ đ©đšđ­đĄđšđ„đšđ đąđœđšđ„ đšđ đ đ«đžđ đšđ­đąđšđ§ 𝐱𝐧𝐭𝐹 đąđ§đŹđšđ„đźđ›đ„đž đŸđąđ›đ«đąđ„đŹ (đŸđšđ«đŠđąđ§đ  𝐋𝐞𝐰đČ 𝐛𝐹𝐝𝐱𝐞𝐬)

𝐌đČ đ«đžđŹđžđšđ«đœđĄ đ°đšđ«đ€ 𝐹𝐧 đ€đ„đłđĄđžđąđŠđžđ«’𝐬 𝐝𝐱𝐬𝐞𝐚𝐬𝐞 𝐭𝐹𝐝𝐚đČ đœđšđŻđžđ«đŹ 𝐩𝐚𝐧đČ đ­đšđ©đąđœđŹ đąđ§đœđ„đźđđąđ§đ  α-𝐒đČđ§đźđœđ„đžđąđ§, 𝐚 𝟏𝟒𝟎-𝐚𝐩𝐱𝐧𝐹 𝐚𝐜𝐱𝐝 đ©đ«đšđ­đžđąđ§ đ©đ«đąđŠđšđ«đąđ„đČ 𝐟𝐹𝐼𝐧𝐝 𝐱𝐧 đ§đžđźđ«đšđ„ 𝐭𝐱𝐬𝐬𝐼𝐞 (đŹđ©đžđœđąđŸđąđœđšđ„đ„đČ đ©đ«đžđŹđČđ§đšđ©đ­đąđœ đ­đžđ«đŠđąđ§đšđ„đŹ). α-𝐒đČđ§đźđœđ„đžđąđ§ đ©đ„đšđČ𝐬 𝐚 đ€đžđČ đ«đšđ„đž 𝐱𝐧 𝐬đČđ§đšđ©đ­đąđœ đŻđžđŹđąđœđ„đž đ­đ«đšđŸđŸđąđœđ€đąđ§đ , đ§đžđźđ«đšđ­đ«đšđ§đŹđŠđąđ­đ­đžđ« đ«đžđ„đžđšđŹđž, 𝐚𝐧𝐝 đ©đšđ­đžđ§đ­đąđšđ„đ„đČ đ§đžđźđ«đšđ§đšđ„ đŹđźđ«đŻđąđŻđšđ„. đ–đĄđąđ„đž 𝐱𝐭𝐬 đžđ±đšđœđ­ đ©đĄđČđŹđąđšđ„đšđ đąđœđšđ„ 𝐟𝐼𝐧𝐜𝐭𝐱𝐹𝐧 đ«đžđŠđšđąđ§đŹ đźđ§đđžđ« 𝐱𝐧𝐯𝐞𝐬𝐭𝐱𝐠𝐚𝐭𝐱𝐹𝐧, 𝐱𝐭𝐬 đ©đšđ­đĄđšđ„đšđ đąđœđšđ„ đšđ đ đ«đžđ đšđ­đąđšđ§ 𝐱𝐧𝐭𝐹 đąđ§đŹđšđ„đźđ›đ„đž đŸđąđ›đ«đąđ„đŹ (đŸđšđ«đŠđąđ§đ  𝐋𝐞𝐰đČ 𝐛𝐹𝐝𝐱𝐞𝐬) 𝐱𝐬 𝐚 đĄđšđ„đ„đŠđšđ«đ€ 𝐹𝐟 đđšđ«đ€đąđ§đŹđšđ§’𝐬 𝐝𝐱𝐬𝐞𝐚𝐬𝐞 𝐚𝐧𝐝 đšđ­đĄđžđ« đ§đžđźđ«đšđđžđ đžđ§đžđ«đšđ­đąđŻđž 𝐝𝐱𝐬𝐞𝐚𝐬𝐞𝐬 đ€đ§đšđ°đ§ 𝐚𝐬 𝐬đČđ§đźđœđ„đžđąđ§đšđ©đšđ­đĄđąđžđŹ.

𝐊𝐞đČ 𝐅𝐚𝐜𝐭𝐬 𝐀𝐛𝐹𝐼𝐭 đ›Œ-𝐒đČđ§đźđœđ„đžđąđ§:
‱ 𝐋𝐹𝐜𝐚𝐭𝐱𝐹𝐧: 𝐀𝐛𝐼𝐧𝐝𝐚𝐧𝐭 𝐱𝐧 𝐭𝐡𝐞 đ›đ«đšđąđ§ (đœđšđ«đ­đžđ±, đĄđąđ©đ©đšđœđšđŠđ©đźđŹ, đŹđ­đ«đąđšđ­đźđŠ) 𝐚𝐧𝐝 𝐱𝐧 đ©đ„đšđ­đžđ„đžđ­đŹ/đžđ«đČđ­đĄđ«đšđœđČ𝐭𝐞𝐬.
‱ đ’đ­đ«đźđœđ­đźđ«đž: đ‚đšđŠđ©đšđŹđžđ 𝐹𝐟 𝐚𝐧 đšđŠđ©đĄđąđ©đšđ­đĄđąđœ 𝐍-đ­đžđ«đŠđąđ§đźđŹ (đŠđžđŠđ›đ«đšđ§đž 𝐛𝐱𝐧𝐝𝐱𝐧𝐠), 𝐚 𝐡đČđđ«đšđ©đĄđšđ›đąđœ 𝐍𝐀𝐂 đ«đžđ đąđšđ§ (đšđ đ đ«đžđ đšđ­đąđšđ§-đ©đ«đšđ§đž), 𝐚𝐧𝐝 𝐚𝐧 𝐚𝐜𝐱𝐝𝐱𝐜 𝐂-đ­đžđ«đŠđąđ§đźđŹ.
‱ đđšđ­đĄđšđ„đšđ đČ: 𝐈𝐧 đđšđ«đ€đąđ§đŹđšđ§’𝐬, 𝐭𝐡𝐞 đ©đ«đšđ­đžđąđ§ đŠđąđŹđŸđšđ„đđŹ 𝐚𝐧𝐝 đšđ đ đ«đžđ đšđ­đžđŹ, đ„đžđšđđąđ§đ  𝐭𝐹 𝐭𝐡𝐞 đŸđšđ«đŠđšđ­đąđšđ§ 𝐹𝐟 𝐋𝐞𝐰đČ 𝐛𝐹𝐝𝐱𝐞𝐬, 𝐰𝐡𝐱𝐜𝐡 đšđ«đž đ­đšđ±đąđœ 𝐭𝐹 đ§đžđźđ«đšđ§đŹ.
‱ 𝐃𝐱𝐬𝐞𝐚𝐬𝐞𝐬 (𝐒đČđ§đźđœđ„đžđąđ§đšđ©đšđ­đĄđąđžđŹ): đˆđŠđ©đ„đąđœđšđ­đžđ 𝐱𝐧 đđšđ«đ€đąđ§đŹđšđ§’𝐬 𝐝𝐱𝐬𝐞𝐚𝐬𝐞 (𝐏𝐃), 𝐃𝐞𝐩𝐞𝐧𝐭𝐱𝐚 𝐰𝐱𝐭𝐡 𝐋𝐞𝐰đČ 𝐛𝐹𝐝𝐱𝐞𝐬 (𝐃𝐋𝐁), 𝐚𝐧𝐝 đŒđźđ„đ­đąđ©đ„đž 𝐒đČ𝐬𝐭𝐞𝐩 đ€đ­đ«đšđ©đĄđČ (𝐌𝐒𝐀).
‱ 𝐅𝐼𝐧𝐜𝐭𝐱𝐹𝐧: 𝐈𝐭 𝐱𝐬 𝐭𝐡𝐹𝐼𝐠𝐡𝐭 𝐭𝐹 𝐚𝐬𝐬𝐱𝐬𝐭 𝐱𝐧 đ§đžđźđ«đšđ­đ«đšđ§đŹđŠđąđ­đ­đžđ« đ«đžđ„đžđšđŹđž 𝐚𝐧𝐝 𝐬đČđ§đšđ©đ­đąđœ đŻđžđŹđąđœđ„đž đ­đ«đšđŸđŸđąđœđ€đąđ§đ .

đ‘đžđŹđžđšđ«đœđĄ 𝐟𝐹𝐜𝐼𝐬𝐞𝐬 𝐹𝐧 đ«đžđđźđœđąđ§đ  𝐭𝐡𝐞 đ­đšđ±đąđœ 𝐞𝐟𝐟𝐞𝐜𝐭𝐬 𝐹𝐟 đšđœđœđźđŠđźđ„đšđ­đžđÂ đ›Œ-𝐬đČđ§đźđœđ„đžđąđ§ 𝐚𝐬 𝐚 đ­đĄđžđ«đšđ©đžđźđ­đąđœ đ­đšđ«đ đžđ­ đŸđšđ« đ§đžđźđ«đšđđžđ đžđ§đžđ«đšđ­đąđŻđž 𝐝𝐱𝐬𝐞𝐚𝐬𝐞𝐬.

Primary & High-Specificity Keywords: Alpha-synuclein (α-synuclein); Synucleinopathies;
Neurodegenerative diseases; Lewy bodies; Protein aggregation; Parkinson’s disease (PD); Dementia with Lewy bodies (DLB); Multiple System Atrophy (MSA)

Functional & Biological Process Keywords: Synaptic vesicle trafficking; Neurotransmitter release; Neuronal survival; Presynaptic terminals; Protein misfolding; Amyloid fibrils

Structural & Location Keywords: 140-amino acid protein; NAC region (non-amyloid-ÎČ component); Amphipathic N-terminus; Hydrophobic region; Brain cortex; Hippocampus
Striatum; Research & Therapeutic Keywords; Therapeutic target; Alzheimer’s disease research;
Neurotoxicity; Disease mechanisms;
hashtagAlphaSynuclein hashtagSynucleinopathy hashtagParkinsonsDisease hashtagLewyBody hashtagNeurodegeneration hashtagNeuroscience hashtagAlzheimersResearch hashtagProteinAggregation hashtagMSA hashtagDLB hashtagBrainResearch

Responses are currently closed, but you can trackback from your own site.

Comments are closed.